Coronavirus Pandemics Era and Cancer Patients

Detalhes bibliográficos
Autor(a) principal: Tomás, Maria
Data de Publicação: 2021
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista Brasileira de Cancerologia (Online)
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/2430
Resumo: The SARS-CoV-2 virus and variants (Delta and Mu) will not be the last to provoke pandemics. To fight the new coronavirus species and SARS-CoV-2 variants, it will need to surge vaccination efforts, improve surveillance systems of animal reservoirs, use diagnostic efficiently and communicate consistently to health authorities. Cancer patients could develop new SARS-CoV-2 variants when full vaccination should be key to avoid such entanglement. The future of new pandemic around the world will depend on the development of the pan-coronavirus vaccines and the implementation of these measures across the globe.
id INCA-1_64ea456317474fe6360e961d71021eae
oai_identifier_str oai:rbc.inca.gov.br:article/2430
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
repository_id_str
spelling Coronavirus Pandemics Era and Cancer PatientsEra de Coronavirus Pandémico y Pacientes con CáncerA Era do Coronavirus Pandêmico e os Pacientes OncológicosCoronavirusCOVID-19SARS-CoV-2PandemiasNeoplasiasCoronavirusCOVID-19SARS-CoV-2PandemicsNeoplasmsCoronavirusCOVID-19SARS-CoV-2PandemiasNeoplasiasThe SARS-CoV-2 virus and variants (Delta and Mu) will not be the last to provoke pandemics. To fight the new coronavirus species and SARS-CoV-2 variants, it will need to surge vaccination efforts, improve surveillance systems of animal reservoirs, use diagnostic efficiently and communicate consistently to health authorities. Cancer patients could develop new SARS-CoV-2 variants when full vaccination should be key to avoid such entanglement. The future of new pandemic around the world will depend on the development of the pan-coronavirus vaccines and the implementation of these measures across the globe.O vírus SARS-CoV-2 e suas variantes (Delta e Mu) não serão os últimos a provocarem pandemia. Para combater as novas espécies do vírus e suas variantes, será necessário aumentar os esforços de vacinação, melhorar os sistemas de vigilância, usar o diagnóstico de forma eficiente e notificar as autoridades de saúde sistematicamente. Os pacientes com câncer podem desenvolver as novas variantes do vírus SARS-CoV-2, mas a proteção total é a chave para que isso não aconteça. O futuro das novas pandemias em todo o mundo dependerá do desenvolvimento de vacinas contra pancoronavírus e a implementação dessas medidas no mundo inteiro.INCA2021-11-24info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigo de opniãoapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/243010.32635/2176-9745.RBC.2021v67n4.2430Revista Brasileira de Cancerologia; Vol. 67 No. 4 (2021): Oct./Nov./Dec.; e-252430Revista Brasileira de Cancerologia; Vol. 67 Núm. 4 (2021): oct./nov./dic.; e-252430Revista Brasileira de Cancerologia; v. 67 n. 4 (2021): out./nov./dez.; e-2524302176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAenghttps://rbc.inca.gov.br/index.php/revista/article/view/2430/1542Copyright (c) 2021 Revista Brasileira de Cancerologiahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessTomás, Maria2022-10-17T14:02:30Zoai:rbc.inca.gov.br:article/2430Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2022-10-17T14:02:30Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Coronavirus Pandemics Era and Cancer Patients
Era de Coronavirus Pandémico y Pacientes con Cáncer
A Era do Coronavirus Pandêmico e os Pacientes Oncológicos
title Coronavirus Pandemics Era and Cancer Patients
spellingShingle Coronavirus Pandemics Era and Cancer Patients
Tomás, Maria
Coronavirus
COVID-19
SARS-CoV-2
Pandemias
Neoplasias
Coronavirus
COVID-19
SARS-CoV-2
Pandemics
Neoplasms
Coronavirus
COVID-19
SARS-CoV-2
Pandemias
Neoplasias
title_short Coronavirus Pandemics Era and Cancer Patients
title_full Coronavirus Pandemics Era and Cancer Patients
title_fullStr Coronavirus Pandemics Era and Cancer Patients
title_full_unstemmed Coronavirus Pandemics Era and Cancer Patients
title_sort Coronavirus Pandemics Era and Cancer Patients
author Tomás, Maria
author_facet Tomás, Maria
author_role author
dc.contributor.author.fl_str_mv Tomás, Maria
dc.subject.por.fl_str_mv Coronavirus
COVID-19
SARS-CoV-2
Pandemias
Neoplasias
Coronavirus
COVID-19
SARS-CoV-2
Pandemics
Neoplasms
Coronavirus
COVID-19
SARS-CoV-2
Pandemias
Neoplasias
topic Coronavirus
COVID-19
SARS-CoV-2
Pandemias
Neoplasias
Coronavirus
COVID-19
SARS-CoV-2
Pandemics
Neoplasms
Coronavirus
COVID-19
SARS-CoV-2
Pandemias
Neoplasias
description The SARS-CoV-2 virus and variants (Delta and Mu) will not be the last to provoke pandemics. To fight the new coronavirus species and SARS-CoV-2 variants, it will need to surge vaccination efforts, improve surveillance systems of animal reservoirs, use diagnostic efficiently and communicate consistently to health authorities. Cancer patients could develop new SARS-CoV-2 variants when full vaccination should be key to avoid such entanglement. The future of new pandemic around the world will depend on the development of the pan-coronavirus vaccines and the implementation of these measures across the globe.
publishDate 2021
dc.date.none.fl_str_mv 2021-11-24
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigo de opnião
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/2430
10.32635/2176-9745.RBC.2021v67n4.2430
url https://rbc.inca.gov.br/index.php/revista/article/view/2430
identifier_str_mv 10.32635/2176-9745.RBC.2021v67n4.2430
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/2430/1542
dc.rights.driver.fl_str_mv Copyright (c) 2021 Revista Brasileira de Cancerologia
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Revista Brasileira de Cancerologia
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 67 No. 4 (2021): Oct./Nov./Dec.; e-252430
Revista Brasileira de Cancerologia; Vol. 67 Núm. 4 (2021): oct./nov./dic.; e-252430
Revista Brasileira de Cancerologia; v. 67 n. 4 (2021): out./nov./dez.; e-252430
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1797042250183606272

Registros relacionados